CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (171,644)	$ (36,417)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	12,523	12,503
Stock-based compensation	19,949	981
Change in fair value of warrant liability	8,133	640
Telematics devices unreturned	1,616	684
Amortization of debt issuance costs	11,695	796
Noncash interest and other expense	4,388	8,344
Changes in operating assets and liabilities:
Premiums receivable	(2,326)	(1,171)
Accounts receivable	3,526	692
Reinsurance recoverable on paid loss	8,475	4,752
Reinsurance recoverable on unpaid loss	33,941	(4,746)
Prepaid reinsurance premium	13,668	(1,899)
Prepaid expenses and other assets	456	3,636
Deferred transaction costs	3,581	0
Deferred policy acquisition costs, net	(1,951)	(482)
Digital assets, net	(986)	0
Accounts payable and accrued expenses	476	(2,115)
Ceded reinsurance premium payable	(27,000)	(8,683)
Loss and loss adjustment expense reserves	13,705	1,157
Payable to carriers - premiums and LAE, net	(550)	(1,558)
Unearned premium reserve	1,323	2,234
Deferred revenue	(1,220)	249
Deferred tax liability	0	(67)
Other liabilities	(2,109)	1,134
Net cash used in operating activities	(70,331)	(19,336)
Cash flows from investing activities:
Purchases of telematics devices, improvements, and equipment	(5,220)	(6,269)
Payments relating to capitalized website and software development costs	(12,077)	(10,320)
Net change in payable/(receivable) for securities	(624)	225
Purchase of securities	(44,828)	(18,088)
Sales and maturities of marketable securities	19,484	39,040
Net cash (used in) provided by investing activities	(43,265)	4,588
Cash flow from financing activities:
Proceeds from notes payable	2,015	25,880
Payment on notes payable	(69,351)	(222)
Cash – INSU’s trust and cash (net of redemptions)	336,469	0
Proceeds from exercise of common stock options and warrants	4,370	70
Net cash provided by financing activities	273,503	25,728
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents	159,907	10,980
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	50,188	42,887
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	210,095	53,867
Supplemental cash flow data:
Cash paid for interest	3,164	2,233
Non-cash investing and financing transactions:
Net liabilities assumed in the Business Combination	45,516	0
Net exercise of preferred stock warrants	56,160	0
Net exercise of promissory note	415	0
Capitalized website and software development costs included in accrued liabilities	280	125
Capitalized stock-based compensation	639	336
Reclassification of liability to equity for vesting of stock options	169	0
Preferred stock warrant issued in conjunction with note payable	$ 0	$ 12,464